vs

Side-by-side financial comparison of Amer Sports, Inc. (AS) and CABOT CORP (CBT). Click either name above to swap in a different company.

Amer Sports, Inc. is the larger business by last-quarter revenue ($1.1B vs $849.0M, roughly 1.2× CABOT CORP). CABOT CORP runs the higher net margin — 8.6% vs 1.8%, a 6.8% gap on every dollar of revenue. Amer Sports, Inc. produced more free cash flow last quarter ($92.2M vs $57.0M).

Amer Sports, Inc. is a Finnish multinational sporting equipment division based in Helsinki, Finland. Established in 1950 as an industrial conglomerate with interests as diverse as tobacco trading, ship owning and publishing, Amer has gradually evolved into a multinational firm devoted to the production and marketing of sporting goods. The company employs over 9,700 people. Since 2018, Amer has been a subsidiary of Chinese retail conglomerate Anta Sports.

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

AS vs CBT — Head-to-Head

Bigger by revenue
AS
AS
1.2× larger
AS
$1.1B
$849.0M
CBT
Higher net margin
CBT
CBT
6.8% more per $
CBT
8.6%
1.8%
AS
More free cash flow
AS
AS
$35.2M more FCF
AS
$92.2M
$57.0M
CBT

Income Statement — Q1 FY2024 vs Q1 FY2026

Metric
AS
AS
CBT
CBT
Revenue
$1.1B
$849.0M
Net Profit
$19.0M
$73.0M
Gross Margin
52.8%
24.9%
Operating Margin
12.4%
15.2%
Net Margin
1.8%
8.6%
Revenue YoY
-11.1%
Net Profit YoY
-21.5%
EPS (diluted)
$0.05
$1.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AS
AS
CBT
CBT
Q4 25
$849.0M
Q3 25
$899.0M
Q2 25
$923.0M
Q1 25
$936.0M
Q4 24
$955.0M
Q3 24
$1.0B
Q2 24
$1.0B
Q1 24
$1.1B
$1.0B
Net Profit
AS
AS
CBT
CBT
Q4 25
$73.0M
Q3 25
$43.0M
Q2 25
$101.0M
Q1 25
$94.0M
Q4 24
$93.0M
Q3 24
$137.0M
Q2 24
$109.0M
Q1 24
$19.0M
$84.0M
Gross Margin
AS
AS
CBT
CBT
Q4 25
24.9%
Q3 25
24.5%
Q2 25
26.4%
Q1 25
25.7%
Q4 24
24.6%
Q3 24
24.0%
Q2 24
25.2%
Q1 24
52.8%
24.1%
Operating Margin
AS
AS
CBT
CBT
Q4 25
15.2%
Q3 25
15.2%
Q2 25
18.1%
Q1 25
17.3%
Q4 24
16.2%
Q3 24
15.0%
Q2 24
16.9%
Q1 24
12.4%
15.3%
Net Margin
AS
AS
CBT
CBT
Q4 25
8.6%
Q3 25
4.8%
Q2 25
10.9%
Q1 25
10.0%
Q4 24
9.7%
Q3 24
13.7%
Q2 24
10.7%
Q1 24
1.8%
8.2%
EPS (diluted)
AS
AS
CBT
CBT
Q4 25
$1.37
Q3 25
$0.80
Q2 25
$1.86
Q1 25
$1.69
Q4 24
$1.67
Q3 24
$2.41
Q2 24
$1.94
Q1 24
$0.05
$1.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AS
AS
CBT
CBT
Cash + ST InvestmentsLiquidity on hand
$230.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.6B
Total Assets
$3.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AS
AS
CBT
CBT
Q4 25
$230.0M
Q3 25
$258.0M
Q2 25
$239.0M
Q1 25
$213.0M
Q4 24
$183.0M
Q3 24
$223.0M
Q2 24
$197.0M
Q1 24
$206.0M
Total Debt
AS
AS
CBT
CBT
Q4 25
Q3 25
$1.1B
Q2 25
Q1 25
Q4 24
Q3 24
$1.1B
Q2 24
Q1 24
Stockholders' Equity
AS
AS
CBT
CBT
Q4 25
$1.6B
Q3 25
$1.6B
Q2 25
$1.5B
Q1 25
$1.4B
Q4 24
$1.4B
Q3 24
$1.4B
Q2 24
$1.3B
Q1 24
$1.4B
Total Assets
AS
AS
CBT
CBT
Q4 25
$3.8B
Q3 25
$3.8B
Q2 25
$3.8B
Q1 25
$3.8B
Q4 24
$3.6B
Q3 24
$3.7B
Q2 24
$3.6B
Q1 24
$3.6B
Debt / Equity
AS
AS
CBT
CBT
Q4 25
Q3 25
0.70×
Q2 25
Q1 25
Q4 24
Q3 24
0.75×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AS
AS
CBT
CBT
Operating Cash FlowLast quarter
$114.3M
$126.0M
Free Cash FlowOCF − Capex
$92.2M
$57.0M
FCF MarginFCF / Revenue
8.8%
6.7%
Capex IntensityCapex / Revenue
2.1%
8.1%
Cash ConversionOCF / Net Profit
6.02×
1.73×
TTM Free Cash FlowTrailing 4 quarters
$401.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AS
AS
CBT
CBT
Q4 25
$126.0M
Q3 25
$219.0M
Q2 25
$249.0M
Q1 25
$73.0M
Q4 24
$124.0M
Q3 24
$204.0M
Q2 24
$207.0M
Q1 24
$114.3M
$176.0M
Free Cash Flow
AS
AS
CBT
CBT
Q4 25
$57.0M
Q3 25
$155.0M
Q2 25
$188.0M
Q1 25
$1.0M
Q4 24
$47.0M
Q3 24
$112.0M
Q2 24
$155.0M
Q1 24
$92.2M
$133.0M
FCF Margin
AS
AS
CBT
CBT
Q4 25
6.7%
Q3 25
17.2%
Q2 25
20.4%
Q1 25
0.1%
Q4 24
4.9%
Q3 24
11.2%
Q2 24
15.3%
Q1 24
8.8%
13.1%
Capex Intensity
AS
AS
CBT
CBT
Q4 25
8.1%
Q3 25
7.1%
Q2 25
6.6%
Q1 25
7.7%
Q4 24
8.1%
Q3 24
9.2%
Q2 24
5.1%
Q1 24
2.1%
4.2%
Cash Conversion
AS
AS
CBT
CBT
Q4 25
1.73×
Q3 25
5.09×
Q2 25
2.47×
Q1 25
0.78×
Q4 24
1.33×
Q3 24
1.49×
Q2 24
1.90×
Q1 24
6.02×
2.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AS
AS

Americas2$409.6M39%
EMEA1$356.9M34%
Greater China3$205.6M20%
Asia Pacific4$78.2M7%

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

Related Comparisons